qz
AstraZeneca's profit beat expectations as cancer drug sales powered growth

Core earnings per share rose to $2.63 in the second quarter, topping analyst expectations of $2.48, as the company held its full-year and 2030 outlooks [...]

Rating

Innovation

Pricing

Technology

Usability

We have discovered similar tools to what you are looking for. Check out our suggestions for similar AI tools.

Destination
FDA approves at-home pap smear alternative device for cervical cancer screening

The Food and Drug Administration has approved a new device called the Teal Wand, which its creator describes as an "at-home vaginal sample self-collection device for cervical cancer screening.&qu [...]

Match Score: 82.65

Destination
Beat Saber support is ending on PS VR and PS VR2

It's the end of the line for Beat Saber on PS VR and PS VR2. While you'll still be able to buy and play the base game on both platforms, as well as any songs and music packs that were releas [...]

Match Score: 59.45

qz
AstraZeneca posted stronger-than-expected profit and revenue on surging cancer drug sales

Oncology revenue climbed 16% in the quarter, driven by double-digit gains across multiple cancer treatments [...]

Match Score: 52.59

Destination
OpenAI’s new for-profit plan leaves many unanswered questions

OpenAI has abandoned its controversial restructuring plan. In a dramatic reversal, the company said Monday it would no longer try to separate control of its for-profit arm from the non-profit board th [...]

Match Score: 50.19

Destination
What you need to know as Elon Musk's lawsuit against Sam Altman begins

In a few short days, jury selection will begin in the long-awaited Musk v. Altman case. At the end of that process, an Oakland federal court will task nine regular people with deciding if OpenAI defra [...]

Match Score: 43.91

Destination
AI tools for breast cancer detection fall short of radiologists' expectations

About half of 215 surveyed members of the Society of Breast Imaging already use FDA-approved AI tools for breast cancer detection, but the results fall short of expectations. Only 35 percent report lo [...]

Match Score: 42.40

qz
AstraZeneca CFO Dr. Aradhana Sarin breaks down revenue growth goals

AstraZeneca CFO Dr. Aradhana Sarin breaks down revenue growth goals [...]

Match Score: 40.80

qz
AstraZeneca stock sinks after FDA advisers vote against its breast cancer drug

An FDA advisory committee voted 6-3 against camizestrant, citing concerns about the trial design and whether patients benefit long-term [...]

Match Score: 38.40

thenextweb
Akeso’s lung cancer drug reduces death risk by 34%, marking the first Chinese drug at ASCO’s top stage in 61 years

Akeso, the Chinese biotechnology company whose drug ivonescimab was dubbed “biotech’s DeepSeek moment” last year, has reported phase three clinical trial results showing a 34% reduction in the r [...]

Match Score: 38.04